Loading...
•
Dec 31, 2020
Zomedica Q4 2020 Earnings Report
Zomedica reported financial results for the year ended December 31, 2020.
Key Takeaways
Zomedica, a veterinary health company, reported a net loss of $16.9 million for the year ended December 31, 2020, and no revenues as the company is in the development stage.
Zomedica recorded a net loss of approximately $16.9 million, or $0.05 per share, for the year ended December 31, 2020.
The company recorded no revenues in 2020.
Cash and cash equivalents totaled approximately $62.0 million as of December 31, 2020, compared to $0.5 million as of December 31, 2019.
The net loss resulted from R&D expenses of approximately $8.0 million, G&A expenses of approximately $6.0 million, and professional fees of approximately $2.2 million.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...